New Methods Found Promising for Predicting CKD Progression

Dr. Peralta’s study was supported by the National Institute of Neurological Disorders and Stroke, Amgen Corp., the National Institute of Diabetes and Digestive and Kidney Diseases, the Robert Wood Johnson Foundation, and the American Heart Association. Several associates also reported ties to Amgen. Dr. Tangri’s study was supported by a joint initiative of the Kidney Foundation of Canada, the Canadian Institute of Health Research, and the Canadian Society of Nephrology, as well as by the Change Foundation of Ontario. Dr. Tangri and associates reported no financial conflicts of interest.